C. Purdie

C. Purdie, A. Evans, Kirsty Mcneil, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Mode of presentation and skin thickening on ultrasound may predict nodal burden in breast cancer patients with a positive axillary core biopsy.

P. Donnan, C. Purdie, A. Evans, 2020, The British journal of radiology.

Can additional histopathological examination of ultrasound-guided axillary lymph node core biopsies improve preoperative diagnosis of primary breast cancer nodal metastasis?

C. Purdie, L. Jordan, D. Mclean, 2013, Clinical radiology.

Sentinel node biopsy in breast cancer has a greater node positivity rate than axillary node sample: results from a retrospective analysis.

C. Purdie, K. Brauer, L. Baker, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

University of Dundee Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?

A. Thompson, C. Purdie, L. Jordan, 2013 .

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

Bin Tean Teh, Andrew Menzies, Keiran Raine, 2014, eLife.

Dynamic response to heat--a novel physical characteristic of breast cancer.

Stuart I. Brown, C. Purdie, J. Vaidya, 2008, International journal of surgery.

Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy

A. Howell, D. Evans, W. Newman, 2010, Breast Cancer Research and Treatment.

Soft-embalmed human breast tissue as a model for pre-clinical trials of HIFU - preliminary results

A. Melzer, C. Purdie, S. Cochran, 2015, Journal of Therapeutic Ultrasound.

Identification and role of migration stimulating factor isoforms in breast carcinomas

C. Purdie, B. Vojtesek, Sj Jones, 2008, Breast Cancer Research.

Multiparameter DNA content analysis identifies distinct groups in primary breast cancer

A. Thompson, C. Purdie, M. Sales, 2013, British Journal of Cancer.

Efficacy of tumoricidal agents in vitro and in vivo

D. Galloway, J. Mcgregor, C. Purdie, 1995, The British journal of surgery.

Status of the APC Gene in Familial and Sporadic Colorectal Tumours as Determined by Closely Flanking Markers

Yusuke Nakamura, C. Purdie, A. Wyllie, 1990 .

Identification of pathological complete response after neoadjuvant chemotherapy for breast cancer: comparison of greyscale ultrasound, shear wave elastography, and MRI.

C. Purdie, L. Jordan, S. Vinnicombe, 2018, Clinical radiology.

NIHMS662581-supplement-Supplementary data

Pardeep Kumar, Elizabeth Anderson, Jon W. Teague, 2016 .

Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene.

C. Purdie, D. Harrison, S. Howie, 1994, Oncogene.

Biomarker discordance: prospective and retrospective evidence that biopsy of recurrent disease is of clinical utility.

A. Thompson, C. Purdie, S. Vinnicombe, 2012, Cancer biomarkers : section A of Disease markers.

A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma.

C. Purdie, A. Wyllie, P. Carder, 1994, Oncogene.

Clinical value of internal mammary lymph node metastases found incidentally during free flap recipient vessel exposure.

C. Purdie, M. Schaverien, D. Munnoch, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T predict pathological response to neoadjuvant chemotherapy in primary breast cancer

R. Lerski, C. Purdie, S. Vinnicombe, 2017 .

Rapid Communication p53 Expression in Colorectal Tumors

C. Purdie, A. Wyllie, J. Piris, 2007 .

Tissue confirmation of disease recurrence in patients with breast cancer: Pooled analysis of two large prospective studies.

A. Thompson, C. Purdie, L. Jordan, 2010 .

HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice

S. Pinder, J. Bartlett, A. Thompson, 2013, Journal of Clinical Pathology.

Recurrent urachal adenocarcinoma

C. Purdie, D. Besarani, N. Townell, 2003, Journal of clinical pathology.

Shear-wave elastography and greyscale assessment of palpable probably benign masses: is biopsy always required?

C. Purdie, L. Jordan, S. Vinnicombe, 2016, The British journal of radiology.

p53 expression in colorectal tumors.

C. Purdie, A. Wyllie, C. Bird, 1991, The American journal of pathology.

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2022, Histopathology.

High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22.

H. J. Evans, Y. Nakamura, C. Purdie, 1989, Oncogene.

Thymocyte apoptosis induced by p53-dependent and independent pathways

C. Purdie, D. Harrison, A. Wyllie, 1993, Nature.

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)

A. Thompson, J. Dewar, C. Purdie, 2010, Breast Cancer Research.

∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem‐like cells in human ER+ and HER2+ breast cancers

A. Thompson, C. Purdie, B. Vojtesek, 2019, The journal of pathology. Clinical research.

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.

W. Symmans, M. Hung, Seung-Oe Lim, 2018, Molecular cell.

A simple and rapid approach to the problem of tissue contamination and patient identity in histopathologic specimens.

C. Purdie, D. Levison, K. Robertson, 2006, Human pathology.

Processed pseudogenes acquired somatically during cancer development

Andrew Menzies, Adam P. Butler, Jon W. Teague, 2014, Nature Communications.

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

C. Nguyen, I. Bièche, A. Thompson, 2008, Breast Cancer Research.

Macroscopic handling and reporting of breast cancer specimens pre‐ and post‐neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches

S. Pinder, E. Rakha, J. Bartlett, 2015, Histopathology.

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo

M. Hurles, A. Børresen-Dale, M. Stratton, 2017, Nature.

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

Carlos Caldas, Fengtang Yang, Rosalind Eeles, 2015, Genome research.

Patterns of somatic structural variation in human cancer genomes

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2020, Nature.

Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome

A. Thompson, C. Purdie, P. Quinlan, 2012, Breast Cancer Research.

High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer

C. Purdie, L. Baker, A. Thompson, 2010, International journal of cancer.

Histological evaluation of AMPK signalling in primary breast cancer

Philip R Quinlan, Lee Baker, Alastair M Thompson, 2009, BMC Cancer.

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

A. Thompson, C. Purdie, L. Jordan, 2012, Cancer treatment reviews.

Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.

C. Purdie, A. Wyllie, P. Carder, 1993, Oncogene.

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency.

Alain Viari, Sandro Morganella, Alastair Thompson, 2017, Cancer research.

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

E. Birney, M. Ringnér, A. Børresen-Dale, 2016, Nature Communications.

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2020, Nature Communications.

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

E. Birney, M. Ringnér, A. Børresen-Dale, 2019, Nature.

Counting alleles to predict recurrence of early-stage colorectal cancers

S. Goodman, M. Choti, E. Montgomery, 2002, The Lancet.

FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype

A. Thompson, C. Palmer, C. Purdie, 2011, BMC Research Notes.

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism

A. Thompson, D. Lane, C. Purdie, 2008, BMC Cancer.

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial

L. Pusztai, A. Thompson, J. Dewar, 2011, Breast Cancer Research and Treatment.

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

A. Thompson, J. Dewar, C. Purdie, 2010, British Journal of Cancer.

Pre-operative stromal stiffness measured by shear wave elastography is independently associated with breast cancer-specific survival

P. Pharoah, A. Thompson, C. Purdie, 2018, Breast Cancer Research and Treatment.

Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial

A. Thompson, C. Purdie, P. Goodwin, 2015, Breast Cancer Research and Treatment.

Migration Stimulating Factor (MSF): A Novel Biomarker of Breast Cancer Progression

C. Purdie, A. Schor, P. Preece, 2012 .

The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer

A. Thompson, T. Crook, C. Purdie, 2009, British Journal of Cancer.

A prognostic index for operable, node-negative breast cancer

D. Cameron, C. Purdie, H. Stewart, 2004, British Journal of Cancer.

Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer

C. Purdie, D. Adamson, S. Vinnicombe, 2019, Cancer Imaging.

Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course

Jeong Min Lee, W. Oyen, J. Fütterer, 2016, Cancer Imaging.

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients

A. Thompson, D. Lane, C. Purdie, 2011, Breast Cancer Research.

The Informatics Challenges Facing Biobanks: A Perspective from a United Kingdom Biobanking Network

Martin Groves, Philip R. Quinlan, Lee B. Jordan, 2015, Biopreservation and biobanking.

A Practical Approach to the Use of Immunohistochemistry in the Diagnosis and Management of Breast Disease

C. Purdie, 2017 .

Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status

C. Purdie, B. Vojtesek, R. Nenutil, 2014, The Journal of pathology.

High frequency of complex TP53 mutations in CNS metastases from breast cancer

A. Thompson, T. Crook, C. Purdie, 2011, British Journal of Cancer.

17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer

C. Purdie, A. Wyllie, J. Piris, 1995, The Journal of pathology.

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study

A. Thompson, S. Ogston, J. Dewar, 2013, British Journal of Cancer.

HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma

A. Thompson, C. Purdie, L. Jordan, 2010, Histopathology.

Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer

C. Caldas, Meng-Lay Lin, Simak Ali, 2015, Oncotarget.

A comparison of the imaging features of pleomorphic and classical invasive lobular carcinoma

C. Purdie, L. Jordan, S. Vinnicombe, 2018, Breast Cancer Research and Treatment.

Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?

Colin A. Purdie, Sarah J. Vinnicombe, Alastair M. Thompson, 2019, Cancer Imaging.

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases

I. Ellis, E. Provenzano, S. Pinder, 2021, British Journal of Cancer.

TP53 drives invasion through expression of its Δ133p53β variant

J. Reményi, F. Fuller-Pace, A. Thompson, 2016, eLife.

Sentinel lymph node biopsy: Review of the literature and guidelines for pathological handling and reporting

C. Purdie, 2007 .

Meta‐analysis of sentinel node biopsy in ductal carcinoma in situ of the breast

S. Ogston, C. Purdie, A. Thompson, 2008, The British journal of surgery.

Comprehensive molecular characterization of mitochondrial genomes in human cancers

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2017, bioRxiv.

Author Correction: Pan-cancer analysis of whole genomes

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2023, Nature.

p53 mutation, deprivation and poor prognosis in primary breast cancer

A. Thompson, J. Dewar, C. Purdie, 2010, British Journal of Cancer.

Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right.

S. Pinder, D. Rea, E. Rakha, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays

Shazia Akbar, Stephen J McKenna, Alastair M Thompson, 2015, British Journal of Cancer.

Sex differences in oncogenic mutational processes

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2019, Nature Communications.

Non-histopathological parameters associated with upgrade of breast tumours yielding a core biopsy report of histological grade 2 ductal no special type to grade 3 on excision.

C. Purdie, L. Jordan, A. Evans, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A feasibility study of soft embalmed human breast tissue for preclinical trials of HIFU- preliminary results

A. Melzer, C. Purdie, S. Cochran, 2017 .

The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer

F. Fuller-Pace, A. Thompson, C. Purdie, 2010, Oncogene.

NF-kB Complex Activation and Association of αB-Crystallin and Vimentin with Poor Prognosis in Primary Breast Cancer.

C. Purdie, P. Quinlan, S. Bray, 2009 .

αB-crystallin, vimentin and increased p53 expression levels in breast cancer is associated with poor prognosis.

C. Purdie, P. Quinlan, S. Bray, 2009 .

Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma

C. Purdie, J. Piris, 2000, Histopathology.

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2021, Modern Pathology.

Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers

S. Nik-Zainal, P. Span, H. Russnes, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Involved anterior margins after breast conserving surgery: is re-excision required?

C. Purdie, L. Jordan, A. Thompson, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Diseases of the Breast

A. Thompson, J. Dewar, C. Purdie, 1888, Bristol Medico-Chirurgical Journal (1883).

Correlation of X-ray diffraction signatures of breast tissue and their histopathological classification

R. Speller, C. Purdie, L. Jordan, 2017, Scientific Reports.

Author's response to reviews Title: MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism Authors:

D. Lane, C. Purdie, A. Munro, 2008 .

Prediction of pathological complete response to neoadjuvant chemotherapy for primary breast cancer comparing interim ultrasound, Shear Wave elastography and MRI

F. Fuller-Pace, C. Purdie, L. Jordan, 2018, Senologie - Zeitschrift für Mammadiagnostik und -therapie.

Adult Langerhans Cell Histiocytosis Mimicking Paget's Disease of the Nipple

C. Purdie, B. Ansari, Douglas C. Brown, 2005, The breast journal.

Axillary lymph node core biopsy for breast cancer metastases -- how many needle passes are enough?

C. Purdie, L. Jordan, D. Mclean, 2012, Clinical radiology.